Pacira Pharmaceuticals buy melinda
Start price
22.03.17
/
50%
€42.17
Target price
26.04.17
€80.28
Performance (%)
0.53%
End price
26.04.17
€42.39
Summary
This prediction ended on 26.04.17 with a price of €42.39. The BUY prediction by melinda for Pacira Pharmaceuticals closed nearly unchanged. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacira Pharmaceuticals | -7.477% | -7.477% | 11.864% | -41.071% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by melinda for this prediction
In the thread Pacira Pharmaceuticals diskutieren
$ PCRX bekräftigt mit einem Outperform bei Wedbush. $ 89 PT
A +
Stopped prediction by melinda for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€35.51
29.01.19
29.01.19
€42.39
02.05.19
02.05.19
19.77%
02.05.19
02.05.19
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.31
27.08.16
27.08.16
€40.59
27.02.17
27.02.17
7.95%
27.02.17
27.02.17
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.95
19.10.15
19.10.15
€63.14
15.12.15
15.12.15
78.88%
15.12.15
15.12.15